Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SMEDS A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Bankruptcy risk for industry   6.1% 6.1% 6.1% 6.1% 6.1% 6.1% 6.1% 6.1%   Bankruptcy risk   2.1% 1.6% 4.4% 3.5% 1.2% 1.2% 12.2% 12.1%   Credit score (0-100)   70 76 47 52 82 81 4 4   Credit rating   BBB BBB BB BB BBB BBB B B   Credit limit (kDKK)   0.2 5.0 0.0 0.0 76.0 80.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   834 1,017 504 476 973 922 0.0 0.0   EBITDA   325 340 -64.4 3.1 545 630 0.0 0.0   EBIT   201 223 -172 -67.3 544 630 0.0 0.0   Pre-tax profit (PTP)   147.0 184.1 -189.5 -104.5 520.3 635.8 0.0 0.0   Net earnings   102.6 146.6 -152.9 -83.9 408.6 493.7 0.0 0.0   Pre-tax profit without non-rec. items   147 184 -190 -104 520 636 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Tangible assets total   2,201 1,884 1,844 1,926 1,695 1,695 0.0 0.0   Shareholders equity total   2,113 2,151 1,888 1,691 1,985 2,361 1,739 1,739   Interest-bearing liabilities   9.9 12.7 28.4 204 131 92.7 0.0 0.0   Balance sheet total (assets)   3,353 3,179 2,927 2,905 3,290 3,508 1,739 1,739   Net Debt   -736 -902 -741 -278 -1,184 -1,178 -1,739 -1,739     See the entire balance sheet 1000.0 Volume  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   834 1,017 504 476 973 922 0.0 0.0   Gross profit growth   -43.0% 21.8% -50.4% -5.5% 104.2% -5.3% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   -50.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,353 3,179 2,927 2,905 3,290 3,508 1,739 1,739   Balance sheet change%   -19.3% -5.2% -7.9% -0.7% 13.2% 6.6% -50.4% 0.0%   Added value   324.9 340.0 -64.4 3.1 614.0 630.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -138 -435 -147 11 -232 0 -1,695 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.1% 21.9% -34.1% -14.1% 55.9% 68.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.9% 6.3% -5.4% -2.3% 17.7% 19.4% 0.0% 0.0%   ROI %   8.7% 9.6% -8.1% -3.6% 27.3% 28.7% 0.0% 0.0%   ROE %   4.9% 6.9% -7.6% -4.7% 22.2% 22.7% 0.0% 0.0%   1000.0 Solidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Equity ratio %   63.0% 67.7% 64.5% 58.2% 60.3% 67.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -226.6% -265.3% 1,150.8% -9,053.0% -217.3% -186.9% 0.0% 0.0%   Gearing %   0.5% 0.6% 1.5% 12.0% 6.6% 3.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   336.3% 187.9% 117.4% 31.0% 17.5% 21.6% 0.0% 0.0%   1000.0 Liquidity  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Quick Ratio   0.9 1.2 1.0 0.9 1.3 1.6 0.0 0.0   Current Ratio   0.9 1.3 1.0 0.9 1.3 1.7 0.0 0.0   Cash and cash equivalent   746.1 915.0 769.4 481.6 1,314.9 1,270.8 0.0 0.0   1000.0 Capital use efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -133.0 214.8 -23.9 -179.0 320.1 642.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022 2023/4 2023 2024/4 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   325 340 -64 3 614 630 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   325 340 -64 3 545 630 0 0   EBIT / employee   201 223 -172 -67 544 630 0 0   Net earnings / employee   103 147 -153 -84 409 494 0 0